Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
复制标题
DOI:
10.1136/jnnp.2004.060624
复制
发表时间:
2005-12-01
影响因子:
11
通讯作者:
Lucchinetti, CF
中科院分区:
文献类型:
--
作者:
Pittock, SJ;McClelland, RL;Lucchinetti, CF
Background: A pathological classification has been developed of early active multiple sclerosis ( MS) lesions that reveals four patterns of tissue injury: I - T cell/macrophage associated; II - antibody/ complement associated; III - distal oligodendrogliopathy, and IV - oligodendrocyte degeneration in the periplaque white matter. Mechanisms of demyelination in early MS may differ among the subgroups. Previous studies on biopsied MS have lacked clinicopathological correlation and follow up. Critics argue that observations are not generalisable to prototypic MS.Objective: To describe the clinicopathological characteristics of the MS Lesion Project biopsy cohort.Methods: Clinical characteristics and disability of patients with pathologically confirmed inflammatory demyelinating disease ( excluding ADEM) classified immunopathologically ( n = 91) and patients from the Olmsted County MS prevalence cohort ( n = 218) were determined.Results: Most patients who underwent biopsy and had pathologically proved demyelinating disease ultimately developed definite ( n = 70) or probable ( n = 12) MS ( median follow up 4.4 years). Most had a relapsing remitting course and 73% were ambulatory (EDSS